Literature DB >> 19297474

Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized.

Fuan Wang1, John W Barrett, Yiyue Ma, Gregory A Dekaban, Grant McFadden.   

Abstract

Mouse embryo fibroblasts (MEFs) are a widely used cell culture system in life sciences, including virology. Here, we show that although primary MEFs are nonpermissive to myxoma virus replication, the corresponding immortalized MEFs support a highly productive myxoma virus infection. We further demonstrate that this permissive phenotype for myxoma virus in immortalized MEFs is due to the immortalization-associated selective block to the cellular alpha/beta interferon induction machinery involved in responding to myxoma virus challenge. Thus, our report presents a clear example, illustrating that a drastic phenotypic alteration can occur with respect to virus infection between primary cells and their immortalized counterparts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297474      PMCID: PMC2681981          DOI: 10.1128/JVI.02587-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

3.  The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response.

Authors:  Daniel A Muruve; Virginie Pétrilli; Anne K Zaiss; Lindsay R White; Sharon A Clark; P Joel Ross; Robin J Parks; Jurg Tschopp
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

4.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.

Authors:  C Asselin-Paturel; A Boonstra; M Dalod; I Durand; N Yessaad; C Dezutter-Dambuyant; A Vicari; A O'Garra; C Biron; F Brière; G Trinchieri
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

5.  IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA.

Authors:  Kristi L Peters; Heather L Smith; George R Stark; Ganes C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

6.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

7.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

Review 8.  Immune responses to myxoma virus.

Authors:  Peter Kerr; Grant McFadden
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

9.  The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.

Authors:  Mary T Harte; Ismar R Haga; Geraldine Maloney; Pearl Gray; Patrick C Reading; Nathan W Bartlett; Geoffrey L Smith; Andrew Bowie; Luke A J O'Neill
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

10.  RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages.

Authors:  Fuan Wang; Xiujuan Gao; John W Barrett; Qing Shao; Eric Bartee; Mohamed R Mohamed; Masmudur Rahman; Steve Werden; Timothy Irvine; Jingxin Cao; Gregory A Dekaban; Grant McFadden
Journal:  PLoS Pathog       Date:  2008-07-11       Impact factor: 6.823

View more
  11 in total

1.  The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Authors:  M Kim; C T Williamson; J Prudhomme; D G Bebb; K Riabowol; P W K Lee; S P Lees-Miller; Y Mori; M M Rahman; G McFadden; R N Johnston
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

2.  Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism.

Authors:  Svitlana Grekova; Rainer Zawatzky; Rita Hörlein; Celina Cziepluch; Michal Mincberg; Claytus Davis; Jean Rommelaere; Laurent Daeffler
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response.

Authors:  Kristine M Rose; Susan R Weiss
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

Review 4.  The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.

Authors:  Jia Liu; Sonia Wennier; Grant McFadden
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

5.  The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.

Authors:  Marc Schweneker; Susanne Lukassen; Michaela Späth; Michael Wolferstätter; Eveline Babel; Kay Brinkmann; Ursula Wielert; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

6.  Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Authors:  Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Jennifer Altomonte; Alexandra Junger; Günter Schneider; Wolfgang E Thasler; Nobuyuki Kato; Roland M Schmid; Oliver Ebert
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

7.  A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication.

Authors:  Wondimagegnehu M Teferi; Kristopher Dodd; Rob Maranchuk; Nicole Favis; David H Evans
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 8.  The Importance of Physiologically Relevant Cell Lines for Studying Virus-Host Interactions.

Authors:  David Hare; Susan Collins; Breanne Cuddington; Karen Mossman
Journal:  Viruses       Date:  2016-11-01       Impact factor: 5.048

9.  Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model.

Authors:  Bernice Nounamo; Jason Liem; Martin Cannon; Jia Liu
Journal:  Mol Ther Oncolytics       Date:  2017-08-09       Impact factor: 7.200

10.  Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN-Induced Antiviral State in a  Highly Species-Specific Fashion.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  Viruses       Date:  2017-02-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.